Leptospirosis: A zoonotic disease of global importance

Lancet Infectious Diseases

Volumn 3, Issue 12, 2003, Pages 757-771

  Bharti, Ajay R ^a   Nally, Jarlath E ^b   Ricaldi, Jessica N ^c   Matthias, Michael A ^a   Diaz, Monica M ^d   Lovett, Michael A ^b   Levett, Paul N ^e   Gilman, Robert H ^f   Willig, Michael R ^d   Gotuzzo, Eduardo ^c   Vinetz, Joseph M ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^d TEXAS TECH UNIVERSITY   (United States)

^e NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZITHROMYCIN; BACTERIAL VACCINE; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; LEPTOSPIROSIS VACCINE; MOXIFLOXACIN; OFLOXACIN; PENICILLIN G; SULTAMICILLIN; TELITHROMYCIN; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBIOTIC THERAPY; ARTHRALGIA; AUTOIMMUNE DISEASE; CHILL; COUGHING; DEVELOPING COUNTRY; DIAGNOSTIC VALUE; DIARRHEA; EARLY DIAGNOSIS; EPIDEMIOLOGICAL DATA; EYE PAIN; FEVER; GENE SEQUENCE; HEADACHE; HUMAN; IMMUNOPATHOLOGY; INDUSTRIALIZATION; LEPTOSPIRA INTERROGANS; LEPTOSPIRA INTERROGANS LAI; LEPTOSPIROSIS; LUNG HEMORRHAGE; MORTALITY; MYALGIA; NAUSEA; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; RASH; REVIEW; RURAL AREA; SEROTYPING; SIDE EFFECT; SORE THROAT; STRAIN DIFFERENCE; SYMPTOMATOLOGY; URBAN AREA; UVEITIS; VACCINE PRODUCTION; VOMITING; ZOONOSIS;

EID: 0344983453     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(03)00830-2     Document Type: Review

References (158)

1. Vinetz JM. Leptospirosis. Curr Opin Infect Dis 2001; 14: 527-38.
2. Trevejo RT, Rigau-Perez JG, Ashford DA, et al. Epidemic leptospirosis associated with pulmonary haemorrhage-Nicaragua, 1995. J Infect Dis 1998; 178: 1457-63.
3. O'Neil KM, Rickman LS, Lazarus AA. Pulmonary manifestations of leptospirosis. Rev Infect Dis 1991; 13: 705-09.
4. Heron LG, Reiss-Levy EA, Jacques TC, Dickeson DJ, Smythe LD, Sorrell TC. Leptospirosis presenting as a haemorrhagic fever in a traveller from Africa. Med J Aust 1997; 167: 477-79.
5. Monzuez J-J, Kidouche R, Le Gueno, Postic D. Leptospirosis presenting as haemorrhagic fever in visitor to Africa. Lancet 1997; 349: 254-55.
6. Morgan J, Bornstein SL, Karpati AM, et al. Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998. Clin Infect Dis 2002; 34: 1593-99.
7. Haake DA, Dundoo M, Cader R, et al. Leptospirosis, water sports, and chemoprophylaxis. Clin Infect Dis 2002; 34: e40-43.
8. Sasaki DM, Pang L, Minette HP, et al. Active surveillance and risk factors for leptospirosis in Hawaii. Am J Trop Med Hyg 1993; 48: 35-43.
9. Vinetz JM, Glass GE, Flexner CE, Mueller P, Kaslow DC. Sporadic urban leptospirosis. Ann Intern Med 1996; 125: 794-98.
10. Paster BJ, Dewhirst FE, Weisburg WG, et al. Phylogenetic analysis of the spirochetes. J Bacteriol 1991; 173: 6101-09.
11. Dikken H, Kmety E. Serological typing methods of leptospires. In: Bergan T, Norris J, eds. Methods in microbiology. London: Academic Press, 1978: 259-307.
12. Terpstra WJ. Typing leptospira from the perspective of a reference laboratory. Acta Leiden 1992; 60: 79-87.
13. Yasuda PH, Steigerwalt AG, Sulzer KR, Kaufmann AF, Rogers F, Brenner DJ. Deoxyribonucleic acid relatedness between serogroups and serovars in the family Leptospiraceae with proposals for seven new Leptospira species. Int Syst Bacteriol 1987; 37: 407-15.
14. Ramadass P, Jarvis BD, Corner RJ, Penny D, Marshall RB. Genetic characterization of pathogenic Leptospira species by DNA hybridization. Int J Syst Bacteriol 1992; 42: 215-19.
15. Brenner DJ, Kaufmann AF, Sulzer KR, Steigerwalt AG, Rogers FC, Weyant RS. Further determination of DNA relatedness between serogroups and serovars in the family Leptospiraceae with a proposal for Leptospira alexanderi sp nov and four new Leptospira genomospecies. Int J Syst Bacteriol 1999; 49: 839-58.
16. Perolat P, Chappel RJ, Adler B, et al. Leptospira fainei sp nov, isolated from pigs in Australia. Int J Syst Bacteriol 1998; 48: 851-58.
17. Boursaux-Eude C, Saint Girons I, Zuerner R. Leptospira genomics. Electrophoresis 1998; 19: 589-92.
18. Ren SX, Fu G, Jiang XG, et al. Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature 2003; 422: 888-93.
19. Fraser CM, Norris SJ, Weinstock GM, et al. Complete genome sequence of Treponema pallidum, the syphilis spirochete. Science 1998; 281: 375-88.
20. Fraser CM, Casjens S, Huang WM, et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 1997; 390: 580-86.
21. de la Pena-Moctezuma A, Bulach DM, Kalambaheti T, Adler B. Comparative analysis of the LPS biosynthetic loci of the genetic subtypes of serovar hardjo: Leptospira interrogans subtype hardjoprajitno and Leptospira borgpetersenii subtype hardjobovis. FEMS Microbiol Lett 1999; 177: 319-26.
22. Saint Girons I, Bourhy P, Ottone C, et al. The LE1 bacteriophage replicates as a plasmid within Leptospira biflexa: construction of an L biflexa-Escherichia coli shuttle vecto. J Bacteriol 2000; 182: 5700-05.
23. Haake DA. Spirochaetal lipoproteins and pathogenesis. Microbiology 2000; 146: 1491-504.
24. Hovind-Hougen K. Determination by means of electron microscopy of morphological criteria of value for classification of some spirochetes, in particular treponemes. Acta Pathol Microbiol Scand 1976; Suppl 255: 1-41.
25. Charon NW, Goldstein SF. Genetics of motility and chemotaxis of a fascinating group of bacteria: The spirochetes. Annu Rev Genet 2002; 36: 47-73.
26. Ellis WA, Hovind-Hougen K, Müller S, Birch-Andersen A. Morphological changes upon subculturing of freshly isolated strains of Leptospira interrogans serovar hardjo. Zentralbl Bakteriol Mikrobiol Hyg [A] 1983; 255: 323-35.
27. Ellis WA, Michno SW. Bovine leptospirosis: a serological and clinical study. Vet Rec 1976; 99: 387-91.
28. Faine S, Adler B, Bolin C, Perolat P. Leptospira and leptospirosis. 2nd edn. Melbourne, Australia: Medisci, 1999.
29. Ellinghausen HC Jr, McCullough WG. Nutrition of Leptospira pomona and growth of 13 other serotypes: fractionation of oleic albumin complex and a medium of bovine albumin and polysorbate 80. Am J Vet Res 1965; 26: 45-51.
30. Ellinghausen HC, Jr, McCullough WG. Nutrition of Leptospira pomona and growth of 13 other serotypes: a serum-free medium employing oleic albumin complex. Am J Vet Res 1965; 26: 39-44.
31. Johnson RC, Rogers P. Metabolism of leptospires 11. The action of 8-azaguanine. Can J Microbiol 1967; 13: 1621-29.
32. Levett PN. Leptospirosis. Clin Microbiol Rev 2001; 14: 296-326.
33. Kmety E, Dikken H. Classification of the species Leptospira interrogans and the history of its serovars. A history of the publication of the serovars of leptospires, and a catalogue of their relationships. Groningen, Netherlands: University Press Groningen, 1993.
34. Bovet P, Yersin C, Merien F, Davis CE, Perolat P. Factors associated with clinical leptospirosis: a population-based case-control study in the Seychelles (Indian Ocean). Int J Epidemiol 1999; 28: 583-90.
35. Ashford DA, Kaiser RM, Spiegel RA, et al. Asymptomatic infection and risk factors for leptospirosis in Nicaragua. Am J Trop Med Hyg 2000; 63: 249-54.
36. Leonard FC, Quinn PJ, Ellis WA, K OF. Duration of urinary excretion of leptospires by catfle naturally or experimentally infected with Leptospira interrogans serovar hardjo. Vet Rec 1992; 131: 435-39.
37. Thiermann AB. The Norway rat as a selective chronic carrier of Leptospira icterohaemorrhagiae. J Wildl Dis 1981; 17: 39-43.
38. Matthias MA, Levett PN. Leptospiral carriage by mice and mongooses on the island of Barbados. West Indian Med J 2002; 51: 10-13.
39. Tomich P. Studies of leptospirosis in natural host populations I. Small mammals of Waipio Valley, island of Hawaii. Pacific Science 1979; 33: 257-79.
40. Alexander AD, Byrne RJ, Evans LB, et al. Leptospirosis in Puerto Rico. Zoonoses Res 1963; 2: 152-27.
41. Sulzer C. Leptospiral serotype distribution lists according to host and geographic area July 1966 to July 1973. Atlanta: US Department of Health, Education, and Welfare, 1975.
42. Everard CO, Sulzer CR, Bhagwandin LJ, Fraser-Chanpong GM, James AC. Pathogenic leptospira isolates from the Caribbean Islands of Trinidad, Grenada and St Vincent. Int J Zoonoses 1980; 7: 90-100.
43. Everard CO, Green AE, Glosser JW. Leptospirosis in Trinidad and Grenada, with special reference to the mongoose. Trans R Soc Trop Med Hyg 1976; 70: 57-61.
44. Ko AI, Galvao Reis M, Dourado CMR, Johnson WD, Riley LW. Urban epidemic of severe leptospirosis in Brazil. Lancet 1999; 354: 820-25.
45. St John MA, King S, Bullen SE, Cherian J, Levett PN. Leptospirosis occurring in two children after fresh water immersion. West Indian Med J 2000; 49: 340-43.
46. Sanders EJ, Rigau-Perez JG, Smits HL, et al. Increase of leptospirosis in dengue-negative patients after a hurricane in Puerto Rico in 1996 [correction of 1966]. Am J Trop Med Hyg 1999; 61: 399-404.
47. Bunnell JE, Hice CL, Watts DM, Montrueil V, Tesh RB, Vinetz JM. Detection of pathogenic Leptospira spp infections among mammals captured in the Peruvian Amazon basin region. Am J Trop Med Hyg 2000; 63: 255-58.
48. Russell KL, Montiel Gonzalez MA, Watts DM, et al. An outbreak of leptospirosis among Peruvian military recruits. Am J Trop Med Hyg 2003; 69: 53-57.
49. Sejvar J, Bancroff E, Winthrop K, et al. Leptospirosis in Eco-Challenge Athletes, Malaysian Borneo, 2000. Emerg Infect Dis 2003; 9: 702-07.
50. Levett PN, Walton D, Waterman LD, et al. Surveillance of leptospiral carriage by feral rats in Barbados. West Indian Med J 1998; 47: 15-17.
51. Willig MR. Common trends with latitude. In: Levin SA, ed. Encyclopedia of biodiversity. San Diego, CA: Academic Press, 2001: 701-14.
52. Willig MR, Kaufman DM, Stevens RD. Latitudinal gradients of biodiversity: pattern, process, scale, and synthesis. Annu Rev Ecol Syst (in press).
53. Lux R, Moter A, Shi W. Chemotaxis in pathogenic spirochetes: directed movement toward targeting tissues. J Mol Microbiol Biotechnol 2000; 2: 355-64.
54. Yuri K, Takamoto Y, Okada M, Hiramune T, Kikuchi N, Yanagawa R. Chemotaxis of leptospires to hemoglobin in relation to virulence. Infect Immun 1993; 61: 2270-72.
55. Bernheimer AW, Bey RF. Copurification of Leptospira interrogans serovar pomona hemolysin and sphingomyelinase C. Infect Immun 1986; 54: 262-64.
56. del Real G, Segers RP, van der Zeijst BA, Gaastra W. Cloning of a hemolysin gene from Leptospira interrogans serovar hardjo. Infect Immun 1989; 57: 2588-90.
57. Segers RP, van der Drift A, de Nijs A, Corcione P, van der Zeijst BA, Gaastra W. Molecular analysis of a sphingomyelinase C gene from Leptospira interrogans serovar hardjo. Infect Immun 1990; 58: 2177-85.
58. Lee SH, Kim S, Park SC, Kim MJ. Cytotoxic activities of Leptospira interrogans hemolysin SphH as a poreforming protein on mammalian cells. Infect Immun 2002; 70: 315-22.
59. Merien F, Truccolo J, Baranton G, Perolat P. Identification of a 36-kDa fibronectin-binding protein expressed by a virulent variant of Leptospira interrogans serovar icterohaemorrhagiae. FEMS Microbiol Lett 2000; 185: 17-22.
60. Nally JE, Artiushin S, Timoney JF. Molecular characterization of thermoinduced immunogenic proteins Q1p42 and Hsp15 of Leptospira interrogans. Infect Immun 2001; 69: 7616-24.
61. Nally JE, Timoney JF, Stevenson B. Temperature-regulated protein synthesis by Leptospira interrogans. Infect Immun 2001; 69: 400-04.
62. Cullen PA, Cordwell SJ, Bulach DM, Haake DA, Adler B. Global analysis of outer membrane proteins from Leptospira interrogans serovar lai. Infect Immun 2002; 70: 2311-18.
63. Palaniappan RU, Chang YF, Jusuf SS, et al. Cloning and molecular characterization of an immunogenic LigA protein of Leptospira interrogans. Infect Immun 2002; 70: 5924-30.
64. Harkin KR, Roshto YM, Sullivan JT, Purvis TJ, Chengappa MM. Comparison of polymerase chain reaction assay, bacteriologic culture, and serologic testing in assessment of prevalence of urinary shedding of leptospires in dogs. J Am Vet Med Assoc 2003; 222: 1230-33.
65. Talpada MD, Garvey N, Sprowls R, Eugster AK, Vinetz JM. Prevalence of leptospiral infection Texas cattle: implications for transmission to humans. Vector Borne Zoonotic Dis 2003; 3: 141-47.
66. Yang CW, Wu MS, Pan MJ, et al. Leptospira outer membrane protein activates NF-kappaB and downstream genes expressed in medullary thick ascending limb cells. J Am Soc Nephrol 2000; 11: 2017-26.
67. Barnett JK, Barnett D, Bolin CA, et al. Expression and distribution of leptospiral outer membrane components during renal infection of hamsters. Infect Immun 1999; 67: 853-61.
68. Werts C, Tapping RI, Mathison JC, et al. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol 2001; 2: 346-52.
69. Silva JJ, Dalston MO, Carvalho JE, Setubal S, Oliveira JM, Pereira MM. Clinicopathological and immunohistochemical features of the severe pulmonary form of leptospirosis. Rev Soc Bras Med Trop 2002; 35: 395-99.
70. Alves VA, Gayotto LC, de Brito T, et al. Leptospiral antigens in the liver of experimentally infected guinea pig and their relation to the morphogenesis of liver damage. Exp Toxicol Pathol 1992; 44: 425-34.
71. Alves VA, Gayotto LC, Yasuda PH, Wakamatsu A, Kanamura CT, de Brito T. Leptospiral antigens L interrogans serogroup icterohaemorrhagiae in the kidney of experimentally infected guinea-pigs and their relation to the pathogenesis of renal injury. Exp Pathol 1991; 42: 81-93.
72. Diament D, Brunialti MK, Romero EC, Kallas EG, Salomao R. Peripheral blood mononudear cell activation induced by Leptospira interrogans glycolipoprotein. Infect Immun 2002; 70: 1677-83.
73. Younes-Ibrahim M, Burth P, Faria MV, et al. Inhibition of Na,K-ATPase by an endotoxin extracted from Leptospira interrogans: a possible mechanism for the physiopathology of leptospirosis. C R Acad Sci III 1995; 318: 619-25.
74. Beamer PP, Hugh GG, Firminger H I. Histopathology of experimental leptospirosis. Am J Path 1939; 23: 896-97.
75. Hu QL, Yin QZ, Wu SR, Dai BM, Lei YD. Relationship between the number of leptospires in blood, livers and lungs of guinea pigs and the pulmonary diffuse haemorrhage of leptospirosis. Sichuan Yi Xue Yuan Xue Bao 1985; 16: 33-36.
76. Miller NG, Allen JE, Wilson RB. The pathogenesis of haemorrhage in the lung of the hamster during acute leptospirosis. Med Microbiol Immunol 1974; 160: 269-78.
77. Abdulkader RC, Daher EF, Camargo ED, Spinosa C, da Silva MV. Leptospirosis severity may be associated with the intensity of humoral immune response. Rev Inst Med Trop Sao Paulo 2002; 44: 79-83.
78. Edwards CN, Nicholson GD, Hassell TA, Eerard COR, Callender J. Thrombocytopenia in leptospirosis: the absence of evidence for disseminated intravascular coagulation. Am J Trop Med Hyg 1986; 35: 352-54.
79. Jaroonvesama N, Viranuvatti V, Charoenlarp K. Coagulation studies in leptospirosis. Southeast Asian J Trop Med Public Health 1975; 6: 562-66.
80. Nicodemo AC, Duarte MIS, Alves VAF, Takakura CFH, Santos RTM, Nicodemo EL. Lung lesions in human leptospirosis: microscopic, immunohistochemical, and ultrastructural features related to thrombocytopenia. Am J Trop Med Hyg 1997; 56: 181-87.
81. Higgins R, Cousineau G. The pathogenesis of leptospirosis II. Jaundice in experimental leptospirosis in guinea-pigs. Can J Comp Med 1977; 41: 182-87.
82. da Silva II, Netto BA, Lilembaum W, Alvim ME, de Oliveira AV. The hemorrhagic syndrome of leptospirosis: an experimental study in guinea pigs. Rev Soc Bras Med Trop 1995; 28: 169-77.
83. Rathinam SR, Rathnam S, Selvaraj S, et al. Uveitis associated with an epidemic outbreak of leptospirosis. Am J Ophthalmol 1997; 124: 71-79.
84. Faber NA, Crawford M, LeFebvre RB, Buyukmihci NC, Madigan JE, Willits NH. Detection of Leptospira spp in the aqueous humor of horses with naturally acquired recurrent uveitis. J Clin Microbiol 2000; 38: 2731-73.
85. Brem S, Gerhards H, Wollanke B, Meyer P, Kopp H. Demonstration of intraocular leptospira in 4 horses suffering from equine recurrent uveitis (ERU). Berl Munch Tierarztl Wochenschr 1998; 111: 415-17.
86. Parma AE, Cerone SI, Sansinanea SA, Ghezzi M. C3 fixed in vivo to cornea from horses inoculated with Leptospira interrogans. Ver Immunol Immunopathol 1992; 34: 181-87.
87. Brem S, Gerhards H, Wollanke B, Meyer P, Kopp H. 35 leptospira isolated from the vitreous body of 32 horses with recurrent uveitis (ERU). Berl Munch Tierarzd Wochenschr 1999; 112: 390-93.
88. Adler B, Faine S. Host immunological mechanisms in the resistance of mice to leptospiral infections. Infect Immun 1977; 17: 67-72.
89. Sonrier C, Branger C, Michel V, Ruvoen-Clouet N, Ganiere JP, Andre-Fontaine G. Evidence of cross-protection within Leptospira interrogans in an experimental model. Vaccine 2000; 19: 86-94.
90. Adler B, Faine S. Serological cross-reactions of leptospiral lipopolysaccharide (F4) antigen. Zentralbl Bakteriol[OrigA] 1979; A244: 291-301.
91. Haake DA, Mazel MK, McCoy AM, et al. Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection. Infect Immun 1999; 67: 6572-82.
92. Truccolo J, Serais O, Merien F, Perolat P. Following the course of human leptospirosis: evidence of a critical threshold for the vital prognosis using a quantitative PCR assay. FEMS Microbiol Lett 2001; 204: 317-21.
93. Naiman BM, Alt D, Bolin CA, Zuerner R, Baldwin CL. Protective killed Leptospira borgpetersenii vaccine induces potent Th1 immunity comprising responses by CD4 and gamma-delta T lymphocytes. Infect Immun 2001; 69: 7550-58.
94. Pereira MM, Andrade J, Marchewsky RS, Dos Santos RR. Morphological characterisation of lung and kidney lesions in C3H/HeJ mice infected with Leptospira interrogans serovar icterohaemorrhagiae: defect of CD4+ and CD8+ T-cells are prognosticators of the disease progression. Exp Toxicol Pathol 1998; 50: 191-98.
95. Klimpel GR, Matthias MA, Vinetz JM. Leptospira interrogans activation of human peripheral blood mononuclear cells: preferential expansion of TCRgammadelta(+) T cells vs TCRalphabeta(+) T cells. J Immunol 2003; 171: 1447-55.
96. Farr RW. Leptospirosis. Clin Infect Dis 1995; 21: 1-8.
97. Heath J CW, Alexander AD, Galton MM. Leptospirosis in the United States. New Engl J Med 1961; 273: 857-922.
98. Takafuji ET, Kirkpatrick JW, Miller RN, et al. An efficacy trial of doxycycline chemoprophylaxis against leptospirosis. N Engl J Med 1984; 310: 497-500.
99. Bolin CA, Koellner P. Human-to-human transmission of Leptospira interrogans by milk. J Infec Dis 1988; 158: 246-47.
100. Katz AR, Ansdell VE, Effler PV, Middleton CR, Sasaki DM. Assessment of the clinical presentation and treatment of 355 cases of laboratory-confirmed leptospirosis in Hawaii, 1974-1998. Clin Infect Dis 2001; 33: 1834-41.
101. Panicker JN, Mammachan R, Jayakumar RV. Primary neuroleptospirosis. Postgrad Med J 2001; 77: 589-90.
102. Heath CW, Alexander AD, Galton MM. Leptospirosis in the United States. Analysis of 483 cases in man, 1949-1961. N Engl J Med 1965; 273: 857-64 and 915-22.
103. Moseley RH. Sepsis-associated cholestasis. Gastroenterology 1997; 112: 302-06.
104. Abdulkader RC. Acute renal failure in leptospirosis. Ren Fail 1997; 19: 191-98.
105. Daher E, Zanetta DM, Cavalcante MB, Abdulkader RC. Risk factors for death and changing patterns in leptospirosis acute renal failure. Am J Trop Med Hyg 1999; 61: 630-34.
106. Edwards CN. Leptospirosis and pancreatitis. Pediatr Infect Dis J 1999; 18: 399-400.
107. Edwards CN, Nicholson GD, Everard COR. Thrombocytopenia in leptospirosis. Am J Trop Med Hyg 1982; 31: 827-29.
108. Hill MK, Sanders CV. Leptospiral pneumonia. Sem Resp Infect 1997; 12: 44-49.
109. Im JG, Yeon KM, Han MC, et al. Leptospirosis of the lung: radiographic findings in 58 patients. Am J Roentgenol 1989; 152: 955-59.
110. Dupont H, Dupont-Perdrizet D, Perie JL, Zehner-Hansen S, Jarrige B, Daijardin JB. Leptospirosis: prognostic factors associated with mortality. Clin Infect Dis 1997; 25: 720-24.
111. Marotto PC, Nascimento CM, Eluf-Neto J, et al. Acute lung injury in leptospirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clin Infect Dis 1999; 29: 1561-63.
112. Parsons M. Electrocardiographic changes in leptospirosis. BMJ 1965; 2: 201-03.
113. Charon NW, Johnson RC, Muschel LH. Antileptospiral activity in lower-vertebrate sera. Infect Immun 1975; 12: 1386-91.
114. Coursin DB, Updike SJ, Maki DG. Massive rhabdomyolysis and multiple organ dysfunction syndrome caused by leptospirosis. Intensive Care Med 2000; 26: 808-12.
115. Ho KJ, Scully KT. Acute rhabdomyolysis and renal failure in Weil's disease. Ala J Med Sci 1980; 17: 133-37.
116. Rathinam SR. Ocular leptospirosis. Curr Opin Ophthalmol 2002; 13: 381-86.
117. Barkay S, Garzozi H. Leptospirosis and uveitis. Ann Ophthalmol 1984; 16: 164-68.
118. Chu KM, Rathinam R, Namperumalsamy P, Dean D. Identification of Leptospira species in the pathogenesis of uveitis and determination of clinical ocular characteristics in South India. J Infect Dis 1998; 177: 1314-21.
119. Monsuez JJ, Kidouche R, Le Gueno B, Postic D. Leptospirosis presenting as haemorrhagic fever in visitor to Africa. Lancet 1997; 349: 254-55.
120. Heron L, Reiss-Levy E, Jacques T, Dickeson D, Smythe L, Sorrell T. Leptospirosis presenting as a haemorrhagic fever in a traveller from Africa. Med J Aust 1997; 167: 477-79.
121. Watt G, Jongsakul K, Suttinont C. Possible scrub typhus coinfections in Thai agricultural workers hospitalized with leptospirosis. Am J Trop Med Hyg 2003; 68: 89-91.
122. Levett PN. Usefulness of serologic analysis as a predictor of the infecting serovar in patients with severe leptospirosis. Clin Infect Dis 2003; 36: 447-52.
123. Faine S. Guidelines for the the control of leptospirosis. Geneva: World Health Organization, 1982.
124. Weyant RS, Bragg SL, Kaufmann AF. Leptospira and leptonema. In: Murray PR, Baron EJ, Pfaller MA, et al, eds. Manual of clinical microbiology, 7th edn. Washington DC: ASM Press, 1999: 739-45.
125. Wolff JW. The Laboratory diagnosis of leptospirosis. Oxford: Blackwell, 1954.
126. Palmer M, Waitkins SA, Zochowski W. Survival of leptospires in commercial blood culture systems. Zentralbl Bakteriol Mikrobiol Hyg [A] 1984; 257: 480-87.
127. Palmer MF, Zochowski WJ. Survival of leptospires in commercial blood culture systems revisited. J Clin Pathol 2000; 53: 713-14.
128. Smythe LD, Smith IL, Smith GA, et al. A quantitative PCR (TaqMan) assay for pathogenic Leptospira spp. BMC Infect Dis 2002; 2: 13.
129. Cumberland P, Everard CO, Levett PN. Assessment of the efficacy of an IgM-elisa and microscopic agglutination test (MAT) in the diagnosis of acute leptospirosis. Am J Trop Med Hyg 1999; 61: 731-34.
130. Cole JR, Jr., Sulzer CR, Pursell AR. Improved microtechnique for the leptospiral microscopic agglutination test. Appl Microbiol 1973; 25: 976-80.
131. Levett PN, Branch SL, Whittington CU, Edwards CN, Paxton H. Two methods for rapid serological diagnosis of acute leptospirosis. Clin Diagn Lqb Immunol 2001; 8: 349-51.
132. Adler B, Murphy AM, Locarnini SA, Faine S. Detection of specific anti-leptospiral immunoglobulins M and G in human serum by solid-phase enzyme-linked immunosorbent assay. J Clin Microbiol 1980; 11: 452-57.
133. Terpstra WJ, Ligthart GS, Schoone GJ. ELISA for the detection of specific IgM and IgG in human leptospirosis. J Gen Microbiol 1985; 131: 377-385.
134. Watt G, Padre LP, Tuazon ML, et al. Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet 1988; 1: 433-35.
135. Flannery B, Costa D, Carvalho FP, et al. Evaluation of recombinant leptospira antigen-based enzyme-linked immunosorbent assays for the serodiagnosis of leptospirosis. J Clin Microbiol 2001; 39: 3303-10.
136. Winslow WE, Merry DJ, Pirc ML, Devine PL. Evaluation of a commercial enzyme-linked immunosorbent assay for detection of immunoglobulin M antibody in diagnosis of human leptospiral infection. J Clin Microbiol 1997; 35: 1938-42.
137. Smits HL, Ananyina YV, Chereshsky A, et al. International multicenter evaluation of the clinical utility of a dipstick assay for detection of leptospira-specific immunoglobulin M antibodies in human serum specimens. J Clin Microbiol 1999; 37: 2904-09.
138. Levett PN, Branch SL. Evaluation of two enzyme-linked immunosorbent assay methods for detection of immunoglobulin M antibodies in acute leptospirosis. Am J Trop Med Hyg 2002; 66: 745-48.
139. Bajani MD, Ashford DA, Bragg SL, et al. Evaluation of four commercially available rapid serologic tests for diagnosis of leptospirosis. J Clin Microbiol 2003; 41: 803-09.
140. Vinetz JM. A Mountain out of a molehill: do we treat acute leptospirosis, and ifso, with what? Clin Infect Dis 2003; 36: 1514-15.
141. Edwards CH, Nicholson GD, Hassell TA, Everard COR, Callender J. Penicillin therapy in icteric leptospirosis. Am J Trop Med Hyg 1988; 39: 388-90.
142. Guidugli F, Castro AA, Atallah AN. Systematic reviews on leptospirosis. Rev Inst Med Trop Sao Paulo 2000; 42: 47-49.
143. Guidugli F, Castro AA, Atallah AN. Antibiotics for preventing leptospirosis. Cochrane Database Syst Rev 2000: CD001305.
144. Panaphut T, Domrongkitchaiporn S, Vibhagool A, Thinkamrop B, Susaengrat W. Ceftriaxone compared with sodium penicillin g for treatment of severe leptospirosis. Clin Infect Dis 2003; 36: 1507-13.
145. Truccolo J, Charavay F, Merien F, Perolat P. Quantitative PCR assay to evaluate ampicillin, ofloxacin, and doxycycline for treatment of experimental leptospirosis. Antimicrob Agents Chemother 2002; 46: 848-53.
146. Hospenthal DR, Murray CK. In vitro susceptibilities of seven Leptospira species to traditional and newer antibiotics. Antimicrob Agents Chemother 2003; 47: 2646-48.
147. Sehgal SC, Sugunan AP, Murhekar MV, Sharma S, Vijayachari P. Randomized controlled trial of doxycycline prophylaxis against leptospirosis in an endemic area. Int J Antimicrob Agents 2000; 13: 249-55.
148. Bharadwaj R, Bal AM, Joshi SA, et al. An urban outbreak of leptospirosis in mumbai, India. Jpn J Infect Dis 2002; 55: 194-96.
149. Martinez Sanchez R, Obregon Fuentes AM, Perez Sierra A, et al. The reactogenicity and immunogenicity of the first Cuban vaccine against human leptospirosis. Rev Cubana Med Trop 1998; 50: 159-66.
150. Martinez Sanchez R, Perez Sierra A, Baro Suarez M, et al. Evaluation of the effectiveness of a new vaccine against human leptospirosis in groups at risk. Rev Panam Salud Publica 2000; 8: 385-92.
151. Ikoev VN, Gorbunov MA, Vachaev BF, et al. The evaluation of the reactogenicity and immunogenic activity of a new concentrated inactivated leptospirosis vaccine. Zh Mikrobiol Epidemiol Immunobiol 1999: 39-43.
152. Chen TZ. Development and situation of and techniques for production of leptospirosis vaccine in China. Jpn J Bacteriol 1985; 40: 755-62.
153. Petersen AM, Boye K, Blom J, Schlichting P, Krogfelt KA. First isolation of Leptospira fainei serovar hurstbridge from two human patients with Weil's syndrome. J Med Microbiol 2001; 50: 96-100.
154. Frolov VM, Peresadin NA, Baklanova AV. Clinical assessment of autoimmune and immunocomplex reactions in patients with leptospirosis. Klin Med (Mosk) 1996; 74: 68.
155. Alexander CS, Keller H. Etiology and occurrence of periodic eye inflammation of horses in the area of Berlin. Tierarztl Prax 1990; 18: 623-27.
156. Feigin RD, Lobes LA, Anderson D, Pickering L. Human leptospirosis from immunized dogs. Ann Intern Med 1973; 79: 777-85.
157. Bolin CA, Alt DP. Use of a monovalent leptospiral vaccine to prevent renal colonization and urinary shedding in cattle exposed to Leptospira borgpetersenii serovar hardjo. Am J Vet Res 2001; 62: 995-1000.
158. Guerreiro H, Croda J, Flannery B, et al. Leptospiral proteins recognized during the humoral immune response to leptospirosis in humans. Infect Immun 2001; 69: 4958-68.